Table 1.

Summary of MGL expression in patient primary normal and tumor samples^*.

Tissue	Decreased MGL Expression	Tissue	Decreased MGL Expression
Colon	59.4% (60/101)	Ovary	50% (7/14)
Rectum	50% (9/18)	Prostate	50 (2/4)
Breast	61% (32/52)	Kidney	35% (7/20)
Lung	79% (19/24)	Uterus	23.8% (10/42)
Stomach	50% (14/28)	Thyroid	0% (0/6)

^*For colon tissues, MGL down or loss expression was detected by Cancer Profiling Array (21/34), Northern blotting (4/4) and Western blotting (33/61), immunohistochemistry (2/2). For breast tissues, information presented here includes data generated by Cancer Profiling Array assay (50 pairs) and Western Blotting (2 pairs). For lung tissues, information was from Cancer Profiling Array (21 pairs) and Western (three pairs). For all other tissues, information was from Cancer Profiling Array only.